High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement

Autoimmunity

Volumn 44, Issue 2, 2011, Pages 129-136

  Hansson, Ida ^a   Lynch, Kristian F ^a   Hallmans, Göran ^b   Lernmark, Åke ^a   Rolandsson, Olov ^b  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Latent autoimmune diabetes in adults; radio binding assay; stiff person syndrome; type 1 diabetes; type 2 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE 65 ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; EXPRESSION VECTOR; FEMALE; HUMAN; IN VITRO STUDY; LATENT AUTOIMMUNE DIABETES IN ADULT; MAJOR CLINICAL STUDY; MALE; PLASMID; PROTEIN BINDING; RADIOASSAY;

ADULT; ANTIBODY SPECIFICITY; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC VECTORS; GLUTAMATE DECARBOXYLASE; HUMANS; METHIONINE; MIDDLE AGED; PLASMIDS; RADIOIMMUNOASSAY; RECOMBINANT PROTEINS; SULFUR RADIOISOTOPES;

EID: 79551519263     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2010.482117     Document Type: Article

References (28)

1. Bingley PJ, Gale EAM. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: The role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006;49: 881-890.
2. Schranz DB, Lernmark A. Immunology in diabetes: An update. Diabetes Metab Rev 1998;14:3-29.
3. Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev 2006;5(6):424-428.
4. Lernmark A. Glutamic acid decarboxylase-Gene to antigen to disease. J Intern Med 1996;240:259-277.
5. Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B. TEDDY-The environmental determinants of diabetes in the young: An observational clinical trial. Ann N Y Acad Sci 2006;1079:320-326.
6. Desai M, Clark A. Autoimmune diabetes in adults: Lessons from the UKPDS. Diabetic Med 2008;25:30-34.
7. Castleden HAJ, Shields B, Bingley PJ, Williams AJK, Sampson M, Walker M, Gibson JM, McCarthy MI, Hitman GA, Levy JC, Hattersley AT, Vaidya B, Pearson ER. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes. Diabetic Med 2006;23: 834-838.
8. Maruyama T, Oak S, Shimada A, Hampe CS. GAD65 Autoantibody responses in Japanese latent autoimmune diabetes in adult patients. Diabetes Care 2008;31:1602-1607.
9. Gilliam LK, Palmer JP. Latent autoimmune diabetes in adults. Insulin 2006;1:122-127.
10. Huriya B, Thomas O, David R, Leslie G. progression of autoimmune diabetes: Slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult. Ann N Y Acad Sci 2006;1079:81-89.
11. Juneja R, Palmer JP. Type 1 1/2 diabetes: Myth or reality? Autoimmunity 1999;29:65-83.
12. Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS. Multiplicity of the antibody response to GAD65 in Type I diabetes. Clin Exp Immunol 2004;138:337-341.
13. Fenalti G, Hampe CS, O'Connor K, Banga JP, Mackay IR, Rowley MJ, El-Kabbani O. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. Mol Immunol 2007;44:1178-1189.
14. Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark A. A novel monoclonal antibody specific for the N-terminal end of GAD65. J Neuroimmunol 2001;113:63-71.
15. Schlosser M, Banga JP,Madec AM, Binder KA, StrebelowM, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk for developing type 1 diabetes. Diabetologia 2005;48:922-930.
16. Hampe CS, Kockum I, Landin-Olsson M, Törn C, Ortqvist E, Persson B, Rolandsson O, Palmer J, Lernmark A. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 2002;25(8):1481-1482.
17. Daka B, Svensson MK, Lernmark A, Mincheva-Nilsson L, Hallmans G, Rolandsson O. Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. Autoimmunity 2009;42:507-514.
18. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37(4):344-350.
19. Falorni A, Ortqvist E, Persson B, Lernmark A. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Meth 1995;186(1):89-99.
20. Sohnlein P, Müller M, Syren K, Hartmann U, Bohm BO, Meinck HM, Knip M, Akerblom HK, Richter W. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. Diabetologia 2000;43: 210-217.
21. Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, Dina C, Froguel P, Mohlke KL, Willer C, Olsson T, Wareham NJ, Hallmans G, Barroso I, Sandhu MS. Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 2008;51:523.
22. Richter W, Eiermann TH, Endl J, Seissler J, Wolfahrt S, Brandt M, Jungfer H, Scherbaum WA. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 1993;36(8):785-790.
23. Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Meth 1988;106(1):83-88.
24. Mire-Sluis AR, Gaines Das R, Lernmark A. TheWorld Health Organization International Collaborative Study for islet cell antibodies. Diabetologia 2000;43(10):1282-1292.
25. Olsson ML, Sundkvist G, Lernmark A. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulindependent) diabetes mellitus. Diabetologia 1987;30(5): 327-332.
26. Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulindependent diabetes mellitus. Trends Neurosci 1991;14(10): 452-457.
27. Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T. GAD65 IgG autoantibodies in stiff person syndrome: Clonality, avidity and persistence. Eur J Neurol 2008;15:973-980.
28. Socialstyrelsen,Ovanliga Diagnoser, Stiff Person Syndrome [Internet], Available at: www.socialstyrelsen.se/ovanligadiagnoser/ Stiff+person+syndrome